Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks
Adhesive Capsulitis, Post-operative Pain
About this trial
This is an interventional treatment trial for Adhesive Capsulitis focused on measuring UCSD, pain, quality-of-life, range-of-motion, interscalene catheter, nerve block, shoulder, Shoulder Manipulation
Eligibility Criteria
Inclusion Criteria:
- Undergoing theraputic manipulation for adhesive capsulitis of the shoulder
- age 18 years or older
- accepting a single-injection nerve block for manipulation
- understanding possible perineural infusion-related complications, study protocol, and catheter/pump care
- having caretaker through the first night after manipulation
- having an ASA physical status classification of 1-3
Exclusion Criteria:
- Any contraindications for a CISB
- any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery
- known allergy or other contraindication to the study medications
- pregnancy
- known hepatic or renal insufficiency/disease
- peripheral neuropathy of the surgical extremity
- morbid obesity
- inability to communicate with the investigators and hospital staff
- moderate-to-severe shoulder arthritis
- immunocompromised status of any etiology
- incarceration
Sites / Locations
- UCSD Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
1. 0.2% Ropivicaine perinueral infusion
2. Normal Saline perineural infusion
Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy). They will then be randomized to 0.2% Ropivicaine attached to the perineural catheter and an infusion will be initiated. The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.
Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy). They will then be randomized to normal saline attached to the perineural catheter and an infusion will be initiated. The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.